FDA gene therapy head raises concern on accelerated approval use


14 February 2023 - More than 1,000 cell and gene therapy clinical trials registered.

More cell and gene therapies will likely come to market using FDA’s accelerated approval pathway, a shift that raises concerns for the agency’s outgoing gene therapy head since it could take a while to prove definitively that they work.

Read Bloomberg Law article

Michael Wonder

Posted by:

Michael Wonder